Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy

Banri Ogawa1, Toshiro Kamoshida1, Asaji Yamamoto1

  • 1Department of Gastroenterology, Hitachi General Hospital, Japan.

PubMed
Summary

Hepatitis B virus (HBV) reactivation occurred in an elderly patient with isolated anti-HBc antibodies during rituximab chemotherapy. Reactivation led to hepatic failure, but Tenofovir alafenamide fumarate treatment was effective.